Development of Potential Antitumor Agents. Synthesis and Biological Evaluation of a New Set of Sulfonamide Derivatives as Histone Deacetylase Inhibitors
作者:Giliane Bouchain、Silvana Leit、Sylvie Frechette、Elie Abou Khalil、Rico Lavoie、Oscar Moradei、Soon Hyung Woo、Marielle Fournel、Pu T. Yan、Ann Kalita、Marie-Claude Trachy-Bourget、Carole Beaulieu、Zuomei Li、Marie-France Robert、A. Robert MacLeod、Jeffrey M. Besterman、Daniel Delorme
DOI:10.1021/jm020377a
日期:2003.2.1
and anilides have been synthesized and studied as histone deacetylase (HDAC) inhibitors that can induce hyperacetylation of histones in human cancer cells. The inhibition of HDAC activity represents a novel approach for intervening in cell cycle regulation. The lead candidates were screened in a panel of human tumor and normal cell lines. They selectively inhibit proliferation, cause cell cycle blocks
Fully automated multi-step solution phase synthesis using polymer supported reagents: preparation of histone deacetylase inhibitors
作者:Emma Vickerstaffe、Brian H. Warrington、Mark Ladlow、Steven V. Ley
DOI:10.1039/b305713e
日期:——
The first fully automated multi-step polymer assisted solution phase (PASP) synthesis is described. An array of histone deacetylase (HDAc) inhibitors was prepared by an unattended 4–5 step sequence incorporating in-line ‘catch and release’ purification.
Histone deacetylase inhibitors (HDACs) have emerged as a novel class of antiproliferative agents. Utilizing structure-based design, the synthesis of a series of sulfonamide hydroxamic acids is described. Further optimization of this series by substitution of the terminal aromatic ring yielded HDAC inhibitors with good in vitro and in vivo activities. (C) 2001 Elsevier Science Ltd. All rights reserved.
Polymer-assisted, multi-step solution phase synthesis and biological screening of histone deacetylase inhibitors
作者:Akanksha Bapna、Emma Vickerstaffe、Brian H. Warrington、Mark Ladlow、Tai-Ping D. Fan、Steven V. Ley
DOI:10.1039/b313414h
日期:——
The polymer-assisted solution phase synthesis (PASP) of an array of histone deacetylase (HDAc) inhibitors is described. HDAc inhibitors have considerable potential as new anti-proliferative agents. Selected compounds were shown to inhibit both human endothelial cell proliferation, and the formation of tubules (neovascularisation) in an in vitro model of angiogenesis.